Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
FDA reversal sends mixed message to multiple sclerosis community.
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
[Demyelinating diseases in children with acute neurological symptoms].
The Retinal Nerve Fiber Layer of Patients With Neuromyelitis Optica and Chronic Relapsing Optic Neuritis is More Severely Damaged than Patients With Multiple Sclerosis.
Is neuropsychological rehabilitation effective in multiple sclerosis?
Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process.
Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Twenty years of experience on stem cell transplantation in iran.
Clinical response and tolerability of fampridine in clinical practice.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
[Acute disseminated encephalomyelitis is an important differential diagnosis in the acutely affected child].
Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline.
Atypical presentation of multiple sclerosis.
A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase b1, is a risk factor for multiple sclerosis.
Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation.
Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Pages
« first
‹ previous
…
554
555
556
557
558
559
560
561
562
…
next ›
last »